Logo Logo
Switch Language to German

Ihler, Friedrich; Freytag, Saskia; Kloos, Benedikt; Spiegel, Jennifer Lee; Haubner, Frank; Canis, Martin; Weiß, Bernhard G. and Bertlich, Mattis (2021): Lipopolysaccharide decreases cochlear blood flow dose dependently in a guinea pig animal model via TNF signaling. In: Microcirculation, Vol. 28, No. 4, e12681

Full text not available from 'Open Access LMU'.


Objective To evaluate the effect of Lipopolysaccharide (LPS), a bacterial endotoxin on cochlear microcirculation, and its mode of action. Methods Twenty-five Dunkin-Hartley guinea pigs were divided into five groups of five animals each. After surgical preparation, cochlear microcirculation was quantified by in vivo fluorescence microscopy. Placebo or LPS (1 mg, 10 mu g, and 100 ng) was applied topically, and microcirculation was measured before and twice after application. A fifth group was pretreated with etanercept, a tumor necrosis factor (TNF) antagonist, and afterward the lowest LPS concentrations that yielded significant results (10 mu g) were applied. Results In the groups that had been treated with 1 mg and 10 mu g LPS, a significant drop in cochlear microcirculation was observed after 30 (.791 +/- .089 Arbitrary Units (AU), compared to baseline, and .888 +/- .071AU) and 60 (.756 +/- .101 AU and .817 +/- .124 AU, respectively) minutes. The groups that had been treated with 100 ng LPS and that had been pretreated with etanercept showed no significant change in cochlear blood flow compared to placebo. Conclusion Lipopolysaccharide shows a dose-dependent effect on cochlear microcirculation;this effect can already be observed after 30 min. Pretreatment with etanercept can abrogate this effect, indicating that TNF mediates the effect of LPS on cochlear microcirculation.

Actions (login required)

View Item View Item